Amneal Pharmaceuticals of New York, LLC is recalling 9,056 bottles of Extended Phenytoin Sodium Capsules (100 mg), a prescription medication used to control seizures. The recall was issued because the medication dissolves faster than required by quality standards, which can affect how the body absorbs the drug. No injuries or incidents have been reported in connection with this recall.
If the medication dissolves too quickly, it may lead to higher-than-intended levels of phenytoin in the bloodstream. This increases the risk of phenytoin toxicity, which can cause symptoms such as loss of coordination, involuntary eye movements, and slurred speech.
You have 2 options:
Distributed by Amneal Pharmaceuticals LLC., Bridgewater, NJ 08807
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.